| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
aTyr Pharma Inc (NASDAQ: LIFE)
LIFE Technical Analysis
5
| As on 9th Jun 2023 LIFE SHARE Price closed @ 2.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.05 & Strong Sell for SHORT-TERM with Stoploss of 6.08 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LIFESHARE Price
| Open | 2.27 | Change | Price | % |
| High | 2.27 | 1 Day | -0.06 | -2.65 |
| Low | 2.19 | 1 Week | -0.07 | -3.08 |
| Close | 2.20 | 1 Month | 0.21 | 10.55 |
| Volume | 285200 | 1 Year | -5.57 | -71.69 |
| 52 Week High 7.94 | 52 Week Low 1.72 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LIFE Daily Charts |
LIFE Intraday Charts |
Whats New @ Bazaartrend |
LIFE Free Analysis |
|
|
LIFE Important Levels Intraday
| RESISTANCE | 2.35 |
| RESISTANCE | 2.30 |
| RESISTANCE | 2.27 |
| RESISTANCE | 2.24 |
| SUPPORT | 2.16 |
| SUPPORT | 2.13 |
| SUPPORT | 2.10 |
| SUPPORT | 2.05 |
LIFE Forecast April 2024
| 4th UP Forecast | 6.29 |
| 3rd UP Forecast | 4.98 |
| 2nd UP Forecast | 4.17 |
| 1st UP Forecast | 3.36 |
| 1st DOWN Forecast | 1.04 |
| 2nd DOWN Forecast | 0.23 |
| 3rd DOWN Forecast | -0.58 |
| 4th DOWN Forecast | -1.89 |
LIFE Weekly Forecast
| 4th UP Forecast | 3.68 |
| 3rd UP Forecast | 3.21 |
| 2nd UP Forecast | 2.91 |
| 1st UP Forecast | 2.62 |
| 1st DOWN Forecast | 1.78 |
| 2nd DOWN Forecast | 1.49 |
| 3rd DOWN Forecast | 1.19 |
| 4th DOWN Forecast | 0.72 |
LIFE Forecast2024
| 4th UP Forecast | 15.11 |
| 3rd UP Forecast | 10.97 |
| 2nd UP Forecast | 8.41 |
| 1st UP Forecast | 5.85 |
| 1st DOWN Forecast | -1.45 |
| 2nd DOWN Forecast | -4.01 |
| 3rd DOWN Forecast | -6.57 |
| 4th DOWN Forecast | -10.71 |
aTyr Pharma Inc ( NASDAQ USA Symbol : LIFE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LIFE Business Profile
aTyr Pharma, Inc., a clinical stage biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead clinical product candidate is ATYR1923, a selective modulator of NRP2 for the treatment of patients with severe inflammatory lung diseases, including interstitial lung diseases (ILDs) and severe respiratory complications caused by COVID-19. Its product, ATYR1923, is in Phase 1b/2a multi-center clinical trial for pulmonary sarcoidosis. The company is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of various aggressive cancers. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of ATYR1923 for ILDs in Japan. The company was incorporated in 2005 and is headquartered in San Diego, California. Address: 3545 John Hopkins Court, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service